Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in pretreated advanced myxoid/round cell liposarcoma
2006-005009-69Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jun 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trabectedin in Myxoid/round cell liposarcoma (MRCLS), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoints: Tumor response rate and Patterns of tumor response. Started Jun 2007; status: completed.
02
Drugs
trabectedin
03
Conditions
Myxoid/round cell liposarcoma (MRCLS)
Beyond the preview
Go deeper on 2006-005009-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005009-69.